Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C)

[Edit]

CD263; TNFRSF10-C; DCR1; LIT; TRAILR3; TRID; Decoy Receptor 1; Tnf-Related Apoptosis-Inducing Ligand Receptor 3; Trail Receptor Without An Intracellular Domain

Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C)

TRAILR3, a novel member of the TRAIL receptor family. Although the open reading frame potentially encoded a 299-amino acid protein, the authors suggested that translation begins at amino acid 41, yielding a protein of 259 amino acids. TRAILR3 contains a predicted signal sequence, 2 of the 4 cysteine-rich pseudorepeats characteristic of the extracellular domain of members of the TNF receptor family, an extracellular linker sequence, and a short, hydrophobic C-terminal sequence. Transient expression studies showed that TRAILR3 is a plasma membrane-bound protein capable of high affinity interaction with the TRAIL ligand. In contrast to TRAILR1 and TRAILR2, TRAILR3 appears to be glycosylphosphatidylinositol-linked and lacks a cytoplasmic region, including the death domain.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins RPA137Hu01 Recombinant Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) Positive Control; Immunogen; SDS-PAGE; WB.
Antibodies PAA137Hu01 Polyclonal Antibody to Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) WB; IHC; ICC; IP.
Assay Kits n/a CLIA Kit for Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) CLIA Kit Customized Service Offer
n/a ELISA Kit for Tumor Necrosis Factor Receptor Superfamily, Member 10C (TNFRSF10C) ELISA Kit Customized Service Offer
  1. "Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL."J. Biol. Chem. 272:25417-25420(1997) [PubMed] [Europe PMC] [Abstract]
  2. "Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family."J. Exp. Med. 186:1165-1170(1997) [PubMed] [Europe PMC] [Abstract]
  3. "An antagonist decoy receptor and a death domain-containing receptor for TRAIL."Science 277:815-818(1997) [PubMed] [Europe PMC] [Abstract]
  4. "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors."Science 277:818-821(1997) [PubMed] [Europe PMC] [Abstract]
  5. "Characterization of two receptors for TRAIL."FEBS Lett. 416:329-334(1997) [PubMed] [Europe PMC] [Abstract]
  6. "Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL."J. Immunol. 160:3-6(1998) [PubMed] [Europe PMC] [Abstract]
  7. "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment." Genome Res. 13:2265-2270(2003) [PubMed] [Europe PMC] [Abstract]
  8. "DNA sequence and analysis of human chromosome 8." Nature 439:331-335(2006) [PubMed] [Europe PMC] [Abstract]
  9. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  10. "Signal peptide prediction based on analysis of experimentally verified cleavage sites."Protein Sci. 13:2819-2824(2004) [PubMed] [Europe PMC] [Abstract]